MetaADEDB 2.0 @ LMMD
Canagliflozin
(XTNGUQKDFGDXSJ-ZXGKGEBGSA-N)
Structure
SMILES
OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(s2)c2ccc(cc2)F)C)[C@@H]([C@H]([C@@H]1O)O)O
Type(s)
Approved
ATC code(s)
A10BD16; A10BK02
Molecular Formula:
C24H25FO5S
Molecular Weight:
444.516
Log P:
2.9683
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
4
TPSA:
118.39
CAS Number(s):
842133-18-0; 928672-86-0
Synonym(s)
1.
Canagliflozin
2.
1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973
3.
Canagliflozin Hemihydrate
4.
Canagliflozin, Anhydrous
5.
Invokana
External Link(s)
MeSHD000068896
PubChem Compound24812758
BindingDB50386885
ChEBI73274
CHEMBLCHEMBL2048484
DrugBankDB08907
DrugCentral4758
IUPHAR/BPS Guide to PHARMACOLOGY4582
KEGGdr:D09592
Therapeutic Target DatabaseD08DFX
D0S8XP
ZINC43207238
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Diabetic KetoacidosisFAERS: 1784
Canada Vigilance: 68
Canada Vigilance
US FAERS
2OsteomyelitisFAERS: 1541
Canada Vigilance: 6
Canada Vigilance
US FAERS
3Acute kidney injuryFAERS: 1084
Canada Vigilance: 6
Canada Vigilance
US FAERS
4GangreneFAERS: 727
Canada Vigilance: 1
Canada Vigilance
US FAERS
5CellulitisFAERS: 715
Canada Vigilance: 5
Canada Vigilance
US FAERS
6Urinary tract infectionFAERS: 570
Canada Vigilance: 20
Canada Vigilance
SIDER
US FAERS
7Diabetic FootFAERS: 562
Canada Vigilance: 1
Canada Vigilance
US FAERS
8Diabetic foot infectionFAERS: 510
Canada Vigilance: 1
Canada Vigilance
US FAERS
9KetoacidosisFAERS: 483
Canada Vigilance: 7
Canada Vigilance
US FAERS
10Skin UlcerFAERS: 434
Canada Vigilance: 1
Canada Vigilance
US FAERS
11Weight decreasedFAERS: 417
Canada Vigilance: 2
Canada Vigilance
US FAERS
12DehydrationFAERS: 291
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
13SepsisFAERS: 289
Canada Vigilance: 3
Canada Vigilance
US FAERS
14DizzinessFAERS: 288
Canada Vigilance: 11
Canada Vigilance
SIDER
US FAERS
15Myocardial InfarctionFAERS: 286
Canada Vigilance: 2
Canada Vigilance
US FAERS
16AmputationFAERS: 279
Canada Vigilance: 7
Canada Vigilance
US FAERS
17Adverse eventFAERS: 258US FAERS
18Cerebrovascular accidentFAERS: 249US FAERS
19Drug ineffectiveFAERS: 245
Canada Vigilance: 3
Canada Vigilance
US FAERS
20Genital infection fungalFAERS: 203
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
21Blood glucose increasedFAERS: 196US FAERS
22NauseaFAERS: 194
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
23Diabetic ulcerFAERS: 179US FAERS
24Drug prescribing errorFAERS: 147US FAERS
25Metabolic acidosisFAERS: 142
Canada Vigilance: 2
Canada Vigilance
US FAERS
26Drug dose omissionFAERS: 141US FAERS
27Product use issueFAERS: 132US FAERS
28Incorrect dose administeredFAERS: 122
Canada Vigilance: 3
Canada Vigilance
US FAERS
29PancreatitisFAERS: 119
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
30VomitingFAERS: 107
Canada Vigilance: 6
Canada Vigilance
US FAERS
31HeadacheFAERS: 99US FAERS
32FatigueFAERS: 97
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
33MalaiseFAERS: 97
Canada Vigilance: 3
Canada Vigilance
US FAERS
34Inappropriate schedule of drug administrationFAERS: 96US FAERS
35Urine output increasedFAERS: 95
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
36Back PainFAERS: 93US FAERS
37Blood creatinine increasedFAERS: 89
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
38HypotensionFAERS: 84
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
39Feeling abnormalFAERS: 82US FAERS
40Extremity necrosisFAERS: 77US FAERS
41Gas GangreneFAERS: 77US FAERS
42Dry gangreneFAERS: 76US FAERS
43UrticariaFAERS: 70
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
44DysuriaFAERS: 68US FAERS
45Wrong technique in product usage processFAERS: 67
Canada Vigilance: 8
Canada Vigilance
US FAERS
46AstheniaFAERS: 66
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
47BalanoposthitisFAERS: 66US FAERS
48NephrolithiasisFAERS: 64
Canada Vigilance: 3
Canada Vigilance
US FAERS
49Product use in unapproved indicationFAERS: 63
Canada Vigilance: 2
Canada Vigilance
US FAERS
50HypersensitivityFAERS: 62
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
51ThirstFAERS: 62
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
52PainFAERS: 60
Canada Vigilance: 3
Canada Vigilance
US FAERS
53PruritusFAERS: 54
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
54Vulvovaginal mycotic infectionFAERS: 54
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
55Blood glucose decreasedFAERS: 53
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
56PyelonephritisFAERS: 53
Canada Vigilance: 4
Canada Vigilance
US FAERS
57Unevaluable eventFAERS: 53US FAERS
58Diabetes mellitus inadequate controlFAERS: 51US FAERS
59Abdominal PainFAERS: 50
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
60AlopeciaFAERS: 47US FAERS
61NecrosisFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
62PolyuriaFAERS: 47
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
63Abdominal discomfortFAERS: 45US FAERS
64InfectionFAERS: 45
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
65ConstipationFAERS: 43
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
66Septic ShockFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
67Blood urine presentFAERS: 41US FAERS
68Therapeutic response unexpectedFAERS: 36US FAERS
69UlcerFAERS: 36US FAERS
70ArthralgiaFAERS: 35
Canada Vigilance: 3
Canada Vigilance
US FAERS
71Blood potassium increasedFAERS: 33SIDER
US FAERS
72CystitisFAERS: 33
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
73NocturiaFAERS: 33SIDER
US FAERS
74Peripheral swellingFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
75Chest PainFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
76MyalgiaFAERS: 32US FAERS
77SyncopeFAERS: 32
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
78Vulvovaginal pruritusFAERS: 31
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
79Wrong technique in drug usage processFAERS: 30US FAERS
80PalpitationsFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
81PneumoniaFAERS: 29US FAERS
82Acute respiratory failureFAERS: 28US FAERS
83Flank PainFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
84TremorFAERS: 26US FAERS
85Visual ImpairmentFAERS: 26US FAERS
86Wound InfectionFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Acute myocardial infarctionFAERS: 22US FAERS
88ErythemaFAERS: 22SIDER
US FAERS
89Skin necrosisFAERS: 22US FAERS
90SomnolenceFAERS: 22US FAERS
91AnxietyFAERS: 21US FAERS
92Urinary RetentionFAERS: 21US FAERS
93Wound dehiscenceFAERS: 21US FAERS
94Renal painFAERS: 20US FAERS
95AbscessFAERS: 19US FAERS
96Atrial FibrillationFAERS: 19US FAERS
97Blood triglycerides increasedFAERS: 19US FAERS
98Respiratory FailureFAERS: 19US FAERS
99Urine ketone body presentFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
100AcidosisFAERS: 18US FAERS
101Blood glucose abnormalFAERS: 18US FAERS
102Creatinine renal clearance increasedFAERS: 18US FAERS
103Euglycaemic diabetic ketoacidosisFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
104Genital rashFAERS: 18US FAERS
105Lip swellingFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
106Urinary IncontinenceFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
107prostatitisFAERS: 17US FAERS
108Blood glucose fluctuationFAERS: 16US FAERS
109Erectile dysfunctionFAERS: 16US FAERS
110Genital infectionFAERS: 16US FAERS
111HungerFAERS: 16US FAERS
112Peripheral arterial occlusive diseaseFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
113SwellingFAERS: 15US FAERS
114ThrombosisFAERS: 15US FAERS
115Cardiac ArrestFAERS: 14US FAERS
116FlatulenceFAERS: 14US FAERS
117IncontinenceFAERS: 14US FAERS
118Oral candidiasisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
119TachycardiaFAERS: 14US FAERS
120Burning sensationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
121FractureFAERS: 13SIDER
US FAERS
122LethargyFAERS: 13US FAERS
123Therapy cessationFAERS: 13US FAERS
124Blood urea increasedFAERS: 12SIDER
US FAERS
125GlycosuriaFAERS: 12
Canada Vigilance: 1
28916336CTD
Canada Vigilance
US FAERS
126LeukocytosisFAERS: 12US FAERS
127Product dose omissionFAERS: 12US FAERS
128Intentional product misuseFAERS: 11US FAERS
129Mental impairmentFAERS: 11US FAERS
130Staphylococcal osteomyelitisFAERS: 11US FAERS
131ChromaturiaFAERS: 10US FAERS
132Deep Vein ThrombosisFAERS: 10US FAERS
133DysgeusiaFAERS: 10US FAERS
134DyspepsiaFAERS: 10US FAERS
135GoutFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
136HyperkeratosisFAERS: 10US FAERS
137Medication ErrorFAERS: 10US FAERS
138MicroalbuminuriaFAERS: 10US FAERS
139PolydipsiaFAERS: 10
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
140Skin lesionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
141AmnesiaFAERS: 9US FAERS
142Blood ketone body increasedFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
143Chest discomfortFAERS: 9US FAERS
144ChillsFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
145Creatinine renal clearance decreasedFAERS: 9US FAERS
146DiscomfortFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Drug dispensing errorFAERS: 9US FAERS
148Dry skinFAERS: 9US FAERS
149EmbolismFAERS: 9US FAERS
150Feeling jitteryFAERS: 9US FAERS
151InfluenzaFAERS: 9US FAERS
152Joint swellingFAERS: 9US FAERS
153Limb injuryFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
154NasopharyngitisFAERS: 9US FAERS
155Product packaging quantity issueFAERS: 9US FAERS
156Rash erythematousFAERS: 9SIDER
US FAERS
157RhabdomyolysisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Systemic Inflammatory Response SyndromeFAERS: 9US FAERS
159VertigoFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
160AbasiaFAERS: 8US FAERS
161Activities of daily living impairedFAERS: 8US FAERS
162AngioedemaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
163Blood sodium decreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
164DebridementFAERS: 8US FAERS
165FlushingFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
166HypophagiaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Limb discomfortFAERS: 8US FAERS
168Low density lipoprotein increasedFAERS: 8SIDER
US FAERS
169Memory impairmentFAERS: 8US FAERS
170Neuropathic ulcerFAERS: 8US FAERS
171Penile erythemaFAERS: 8US FAERS
172Renal tubular necrosisFAERS: 8US FAERS
173Vulvovaginal discomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
174VulvovaginitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
175treatment failureFAERS: 8US FAERS
176ArteriosclerosisFAERS: 7US FAERS
177BronchitisFAERS: 7US FAERS
178Cold sweatFAERS: 7US FAERS
179Device related infectionFAERS: 7US FAERS
180Diabetic neuropathic ulcerFAERS: 7US FAERS
181Drug administration errorFAERS: 7US FAERS
182GastritisFAERS: 7US FAERS
183GastroenteritisFAERS: 7US FAERS
184KetonuriaFAERS: 7US FAERS
185Nonspecific reactionFAERS: 7US FAERS
186OverdoseFAERS: 7US FAERS
187PhimosisFAERS: 7SIDER
US FAERS
188Post procedural complicationFAERS: 7US FAERS
189Product quality issueFAERS: 7US FAERS
190Protein urine presentFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
191ProteinuriaFAERS: 7US FAERS
192Pulmonary EmbolismFAERS: 7US FAERS
193Soft tissue necrosisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
194Therapy changeFAERS: 7US FAERS
195Urinary tract infection fungalFAERS: 7US FAERS
196nervous system disorderFAERS: 7SIDER
US FAERS
197Accidental exposure to productFAERS: 6US FAERS
198AcneFAERS: 6US FAERS
199Alanine Aminotransferase IncreasedFAERS: 6US FAERS
200AsthmaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
201BlindnessFAERS: 6US FAERS
202CataractFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
203Diabetic woundFAERS: 6US FAERS
204Drug diversionFAERS: 6US FAERS
205Electrolyte imbalanceFAERS: 6US FAERS
206EpistaxisFAERS: 6US FAERS
207Escherichia infectionFAERS: 6US FAERS
208Extra dose administeredFAERS: 6US FAERS
209HypersomniaFAERS: 6US FAERS
210Lipase increasedFAERS: 6US FAERS
211Mental status changesFAERS: 6US FAERS
212NervousnessFAERS: 6US FAERS
213Oral fungal infectionFAERS: 6US FAERS
214Oropharyngeal painFAERS: 6US FAERS
215Penile InfectionFAERS: 6US FAERS
216Renal tubular acidosisFAERS: 6US FAERS
217StressFAERS: 6US FAERS
218TinnitusFAERS: 6US FAERS
219Vaginal DischargeFAERS: 6US FAERS
220VulvitisFAERS: 6SIDER
US FAERS
221Wound necrosisFAERS: 6US FAERS
222Bladder spasmFAERS: 5US FAERS
223Blood cholesterol increasedFAERS: 5US FAERS
224Blood potassium decreasedFAERS: 5US FAERS
225Bone painFAERS: 5US FAERS
226CalcanectomyFAERS: 5US FAERS
227DermatitisFAERS: 5SIDER
US FAERS
228Diabetes MellitusFAERS: 5SIDER
US FAERS
229Diabetic NephropathyFAERS: 5US FAERS
230Food cravingFAERS: 5US FAERS
231Gastrointestinal infectionFAERS: 5US FAERS
232General physical health deteriorationFAERS: 5US FAERS
233KetosisFAERS: 5US FAERS
234OsteoporosisFAERS: 5US FAERS
235Pancreatic carcinomaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
236Pelvic PainFAERS: 5US FAERS
237Perirectal abscessFAERS: 5US FAERS
238PresyncopeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
239Product packaging issueFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
240Product prescribing errorFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
241Soft Tissue InfectionFAERS: 5US FAERS
242StomatitisFAERS: 5US FAERS
243Vulvovaginal painFAERS: 5US FAERS
244Accidental exposure to product by childFAERS: 4US FAERS
245Accidental overdoseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
246Amylase increasedFAERS: 4US FAERS
247AngerFAERS: 4US FAERS
248Angina PectorisFAERS: 4US FAERS
249Ankle FractureFAERS: 4US FAERS
250ArthritisFAERS: 4US FAERS
251Aspartate Aminotransferase IncreasedFAERS: 4US FAERS
252Bacterial sepsisFAERS: 4US FAERS
253Blood ketone bodyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
254Bone density decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
255Carbon dioxide decreasedFAERS: 4US FAERS
256Cerebral InfarctionFAERS: 4US FAERS
257ChokingFAERS: 4US FAERS
258Dental cariesFAERS: 4US FAERS
259DisabilityFAERS: 4US FAERS
260EczemaFAERS: 4US FAERS
261Emotional distressFAERS: 4US FAERS
262EructationFAERS: 4US FAERS
263Escherichia urinary tract infectionFAERS: 4US FAERS
264FasciitisFAERS: 4US FAERS
265Gastric BypassFAERS: 4US FAERS
266Genital burning sensationFAERS: 4US FAERS
267HepatitisFAERS: 4US FAERS
268HydronephrosisFAERS: 4US FAERS
269Impaired gastric emptyingFAERS: 4US FAERS
270Impaired work abilityFAERS: 4US FAERS
271Inappropriate schedule of product administrationFAERS: 4US FAERS
272Lower respiratory tract infectionFAERS: 4US FAERS
273Middle insomniaFAERS: 4US FAERS
274Multiple allergiesFAERS: 4US FAERS
275Musculoskeletal PainFAERS: 4US FAERS
276MyositisFAERS: 4US FAERS
277OnychomycosisFAERS: 4US FAERS
278PapuleFAERS: 4US FAERS
279Penile burning sensationFAERS: 4US FAERS
280Penile swellingFAERS: 4US FAERS
281Poor quality sleepFAERS: 4US FAERS
282Post procedural infectionFAERS: 4US FAERS
283Product label issueFAERS: 4US FAERS
284Throat irritationFAERS: 4US FAERS
285ThrombocytopeniaFAERS: 4US FAERS
286Urine alcohol test positiveFAERS: 4US FAERS
287Urine flow decreasedFAERS: 4US FAERS
288Vulvovaginal drynessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
289furuncleFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
290AgeusiaFAERS: 3US FAERS
291Anal abscessFAERS: 3US FAERS
292Arterial bypass operationFAERS: 3US FAERS
293Arterial thrombosisFAERS: 3US FAERS
294ArthropathyFAERS: 3US FAERS
295Back disorderFAERS: 3US FAERS
296Bipolar DisorderFAERS: 3US FAERS
297Bladder discomfortFAERS: 3US FAERS
298Bladder painFAERS: 3SIDER
US FAERS
299Blood alcohol increasedFAERS: 3US FAERS
300Blood creatine phosphokinase increasedFAERS: 3US FAERS
301Cerebral ThrombosisFAERS: 3US FAERS
302ColitisFAERS: 3US FAERS
303CystFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
304Depressed moodFAERS: 3US FAERS
305Diabetic encephalopathyFAERS: 3US FAERS
306Drug administered to patient of inappropriate ageFAERS: 3US FAERS
307DysphoniaFAERS: 3US FAERS
308Ejection Fraction DecreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
309Expired product administeredFAERS: 3US FAERS
310Eye irritationFAERS: 3US FAERS
311Hyperosmolar stateFAERS: 3US FAERS
312Infective tenosynovitisFAERS: 3US FAERS
313InflammationFAERS: 3US FAERS
314Intercepted medication errorFAERS: 3US FAERS
315Joint injuryFAERS: 3US FAERS
316LymphangitisFAERS: 3US FAERS
317MenorrhagiaFAERS: 3US FAERS
318Mood swingsFAERS: 3US FAERS
319Muscle necrosisFAERS: 3US FAERS
320Musculoskeletal chest painFAERS: 3US FAERS
321Neck PainFAERS: 3US FAERS
322NeuralgiaFAERS: 3US FAERS
323ObesityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
324OsteopeniaFAERS: 3US FAERS
325PallorFAERS: 3US FAERS
326Pathological fractureFAERS: 3US FAERS
327PeriarthritisFAERS: 3US FAERS
328Perineal cellulitisFAERS: 3US FAERS
329Peripheral artery thrombosisFAERS: 3US FAERS
330Product comminglingFAERS: 3US FAERS
331Product physical issueFAERS: 3US FAERS
332Product substitution issueFAERS: 3US FAERS
333Product use complaintFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
334PsoriasisFAERS: 3US FAERS
335Renal Cell CarcinomaFAERS: 3US FAERS
336Renal abscessFAERS: 3US FAERS
337Stevens-Johnson SyndromeFAERS: 3US FAERS
338Subcutaneous AbscessFAERS: 3US FAERS
339Tinea PedisFAERS: 3US FAERS
340Toe operationFAERS: 3US FAERS
341Tooth InfectionFAERS: 3US FAERS
342ToothacheFAERS: 3US FAERS
343Unresponsive to stimuliFAERS: 3US FAERS
344Upper-airway cough syndromeFAERS: 3US FAERS
345VasculitisFAERS: 3US FAERS
346Ventricular FibrillationFAERS: 3US FAERS
347Vulvovaginal burning sensationFAERS: 3US FAERS
348Wrong drug administeredFAERS: 3US FAERS
349Acute Coronary SyndromeFAERS: 2US FAERS
350Acute prerenal failureFAERS: 2US FAERS
351AgitationFAERS: 2US FAERS
352Alanine aminotransferase decreasedFAERS: 2US FAERS
353Alcohol test false positiveFAERS: 2US FAERS
354Anion GapFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
355Ankle deformityFAERS: 2US FAERS
356AnosmiaFAERS: 2US FAERS
357Apparent deathFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
358AppendicitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
359Aspartate aminotransferase decreasedFAERS: 2US FAERS
360Atrial FlutterFAERS: 2US FAERS
361BedriddenFAERS: 2US FAERS
362Blood alkaline phosphatase increasedFAERS: 2US FAERS
363Blood blisterFAERS: 2US FAERS
364Blood creatinine abnormalFAERS: 2US FAERS
365Blood magnesium decreasedFAERS: 2US FAERS
366Blood magnesium increasedFAERS: 2US FAERS
367Blood pH decreasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
368Blood parathyroid hormone increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
369Blood pressure inadequately controlledFAERS: 2US FAERS
370BradycardiaFAERS: 2US FAERS
371Breast tendernessFAERS: 2US FAERS
372Candida sepsisFAERS: 2US FAERS
373Cellulitis of male external genital organFAERS: 2US FAERS
374CheilitisFAERS: 2US FAERS
375CholelithiasisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
376Chronic respiratory failureFAERS: 2US FAERS
377Clostridium difficile infectionFAERS: 2US FAERS
378Coronary Artery DiseaseFAERS: 2US FAERS
379DeliriumFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
380DisorientationFAERS: 2US FAERS
381Drug ineffective for unapproved indicationFAERS: 2US FAERS
382Drug screen positiveFAERS: 2US FAERS
383Emphysematous pyelonephritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
384EncephalitisFAERS: 2US FAERS
385Enterococcal infectionFAERS: 2US FAERS
386EnuresisFAERS: 2US FAERS
387Erythema MultiformeFAERS: 2US FAERS
388Escherichia sepsisFAERS: 2US FAERS
389Euphoric moodFAERS: 2US FAERS
390Extremity contractureFAERS: 2US FAERS
391Eye painFAERS: 2US FAERS
392Facial PainFAERS: 2US FAERS
393Failure of child resistant mechanism for pharmaceutical productFAERS: 2US FAERS
394Feeling ColdFAERS: 2US FAERS
395FibromyalgiaFAERS: 2US FAERS
396Fungal test positiveFAERS: 2US FAERS
397Gamma-glutamyltransferase decreasedFAERS: 2US FAERS
398Gastrointestinal PainFAERS: 2SIDER
US FAERS
399General physical condition abnormalFAERS: 2US FAERS
400Genital discomfortFAERS: 2US FAERS
401Genital painFAERS: 2US FAERS
402Genital swellingFAERS: 2US FAERS
403Guillain-Barre SyndromeFAERS: 2US FAERS
404Head discomfortFAERS: 2US FAERS
405Hepatic InfectionFAERS: 2US FAERS
406HepatomegalyFAERS: 2US FAERS
407HepatotoxicityFAERS: 2US FAERS
408HyperphagiaFAERS: 2US FAERS
409HypokinesiaFAERS: 2US FAERS
410HysterectomyFAERS: 2US FAERS
411IncoherentFAERS: 2US FAERS
412LacerationFAERS: 2US FAERS
413LaryngitisFAERS: 2US FAERS
414Lesion excisionFAERS: 2US FAERS
415Low density lipoprotein abnormalFAERS: 2US FAERS
416Macular degenerationFAERS: 2US FAERS
417Malignant neoplasm progressionFAERS: 2US FAERS
418MalnutritionFAERS: 2SIDER
US FAERS
419Mouth swellingFAERS: 2US FAERS
420Musculoskeletal stiffnessFAERS: 2US FAERS
421Nail InfectionFAERS: 2US FAERS
422NephritisFAERS: 2US FAERS
423Nephrotic SyndromeFAERS: 2US FAERS
424Oral painFAERS: 2US FAERS
425PhotodermatosisFAERS: 2US FAERS
426PoisoningFAERS: 2US FAERS
427Portal HypertensionFAERS: 2US FAERS
428Procedural complicationFAERS: 2US FAERS
429Product administration errorFAERS: 2US FAERS
430Product container issueFAERS: 2US FAERS
431Product difficult to swallowFAERS: 2US FAERS
432Product lot number issueFAERS: 2US FAERS
433Product storage errorFAERS: 2US FAERS
434Product tamperingFAERS: 2US FAERS
435Pulmonary HypertensionFAERS: 2US FAERS
436Rash papulosquamousFAERS: 2US FAERS
437Renal ColicFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
438Respiratory distressFAERS: 2US FAERS
439Restless Legs SyndromeFAERS: 2US FAERS
440Retinal DetachmentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
441Scrotal InfectionFAERS: 2US FAERS
442SinusitisFAERS: 2US FAERS
443Skin irritationFAERS: 2US FAERS
444Spinal column stenosisFAERS: 2US FAERS
445Staphylococcus testFAERS: 2US FAERS
446Sudden deathFAERS: 2US FAERS
447SunburnFAERS: 2SIDER
US FAERS
448ThrombocytosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
449Tinea crurisFAERS: 2US FAERS
450Toxicity to various agentsFAERS: 2US FAERS
451TroponinFAERS: 2US FAERS
452UrethritisFAERS: 2US FAERS
453Urinary Tract PainFAERS: 2US FAERS
454Urine albumin/creatinine ratio increasedFAERS: 2US FAERS
455Urine calcium increasedFAERS: 2US FAERS
456Urine ketone bodyFAERS: 2US FAERS
457VIIth nerve paralysisFAERS: 2US FAERS
458Vascular ruptureFAERS: 2US FAERS
459Wheelchair userFAERS: 2US FAERS
460Wound ComplicationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
461colonoscopyFAERS: 2US FAERS
462jaundiceFAERS: 2US FAERS
463skin abrasionFAERS: 2US FAERS
464Abdominal AbscessFAERS: 1US FAERS
465Abdominal InfectionFAERS: 1US FAERS
466Abdominal rigidityFAERS: 1US FAERS
467Activated partial thromboplastin time abnormalFAERS: 1US FAERS
468Administration site plaqueFAERS: 1US FAERS
469AgranulocytosisFAERS: 1US FAERS
470AlbuminuriaFAERS: 1US FAERS
471Alcohol interactionFAERS: 1US FAERS
472Alpha hydroxybutyrate dehydrogenase increasedFAERS: 1US FAERS
473AmyloidosisFAERS: 1US FAERS
474Anal candidiasisFAERS: 1US FAERS
475Anaphylactic shockFAERS: 1US FAERS
476AneurysmFAERS: 1US FAERS
477Angular cheilitisFAERS: 1US FAERS
478Anorectal discomfortFAERS: 1US FAERS
479Antibiotic therapyFAERS: 1US FAERS
480Anticoagulation drug level below therapeuticFAERS: 1US FAERS
481Aortic AneurysmFAERS: 1US FAERS
482AphagiaFAERS: 1US FAERS
483AphasiaFAERS: 1US FAERS
484ArthrodesisFAERS: 1US FAERS
485AscitesFAERS: 1US FAERS
486AsthenopiaFAERS: 1US FAERS
487AstigmatismFAERS: 1US FAERS
488Asymptomatic bacteriuriaFAERS: 1US FAERS
489Bacterial VaginosisFAERS: 1US FAERS
490Bacterial testFAERS: 1US FAERS
491Balanoposthitis infectiveFAERS: 1US FAERS
492Benign NeoplasmFAERS: 1US FAERS
493Benign Prostatic HyperplasiaFAERS: 1US FAERS
494Bile Duct StenosisFAERS: 1US FAERS
495Bipolar I disorderFAERS: 1US FAERS
496Bladder NeoplasmFAERS: 1US FAERS
497Bladder cancer recurrentFAERS: 1US FAERS
498BlastomycosisFAERS: 1US FAERS
499BlepharospasmFAERS: 1US FAERS
500Blood GlucoseFAERS: 1US FAERS
501Blood PressureFAERS: 1US FAERS
502Blood count abnormalFAERS: 1US FAERS
503Blood creatinine decreasedFAERS: 1US FAERS
504Blood electrolytes abnormalFAERS: 1US FAERS
505Blood electrolytes decreasedFAERS: 1US FAERS
506Blood glucose normalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
507Blood iron decreasedFAERS: 1US FAERS
508Blood ketone body presentFAERS: 1US FAERS
509Blood lactate dehydrogenase increasedFAERS: 1US FAERS
510Blood osmolarity abnormalFAERS: 1US FAERS
511Blood pH increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
512Blood pH normalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
513Blood phosphorus decreasedFAERS: 1US FAERS
514Blood potassium abnormalFAERS: 1US FAERS
515Blood pressure fluctuationFAERS: 1US FAERS
516Blood sodium abnormalFAERS: 1US FAERS
517Blood testosterone abnormalFAERS: 1US FAERS
518Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
519Blood triglycerides decreasedFAERS: 1US FAERS
520Blood urea abnormalFAERS: 1US FAERS
521Blue Toe SyndromeFAERS: 1US FAERS
522Body temperature fluctuationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
523Brain DeathFAERS: 1US FAERS
524CalciphylaxisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
525Carbon dioxide abnormalFAERS: 1US FAERS
526Cardiac FlutterFAERS: 1US FAERS
527Cardiac stress test abnormalFAERS: 1US FAERS
528Cardiac ventricular disorderFAERS: 1US FAERS
529Carpal Tunnel SyndromeFAERS: 1US FAERS
530Catheter placementFAERS: 1US FAERS
531Cerebellar strokeFAERS: 1US FAERS
532Cervix carcinomaFAERS: 1US FAERS
533CholecystitisFAERS: 1US FAERS
534CholelithotomyFAERS: 1US FAERS
535Cholestatic liver injuryFAERS: 1US FAERS
536ColectomyFAERS: 1US FAERS
537Crystal urine presentFAERS: 1US FAERS
538CyanosisFAERS: 1US FAERS
539Dawn phenomenonFAERS: 1US FAERS
540DeafnessFAERS: 1US FAERS
541Decreased insulin requirementFAERS: 1US FAERS
542DehiscenceFAERS: 1US FAERS
543DemyelinationFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
544Device FailureFAERS: 1US FAERS
545Diabetic arthropathyFAERS: 1US FAERS
546Diabetic glaucomaFAERS: 1US FAERS
547DiplegiaFAERS: 1US FAERS
548DiplopiaFAERS: 1US FAERS
549Disease complicationFAERS: 1US FAERS
550Disease recurrenceFAERS: 1US FAERS
551Diverticular perforationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
552DiverticulitisFAERS: 1US FAERS
553DrowningFAERS: 1US FAERS
554Drug ToleranceFAERS: 1US FAERS
555Drug effect incompleteFAERS: 1US FAERS
556Drug level decreasedFAERS: 1US FAERS
557Drug withdrawal syndromeFAERS: 1US FAERS
558DuodenitisFAERS: 1US FAERS
559DyspareuniaFAERS: 1US FAERS
560DysphemiaFAERS: 1US FAERS
561Ear discomfortFAERS: 1US FAERS
562Economic problemFAERS: 1US FAERS
563Emotional disorderFAERS: 1US FAERS
564Emphysematous cystitisFAERS: 1US FAERS
565EndocarditisFAERS: 1US FAERS
566Enzyme abnormalityFAERS: 1US FAERS
567EosinopeniaFAERS: 1US FAERS
568EosinophiliaFAERS: 1US FAERS
569Epigastric discomfortFAERS: 1US FAERS
570EpiglottitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
571Erythema NodosumFAERS: 1US FAERS
572EscharFAERS: 1US FAERS
573Escherichia pyelonephritisFAERS: 1US FAERS
574Exposure via partnerFAERS: 1US FAERS
575Eye InfectionFAERS: 1US FAERS
576Facial paralysisFAERS: 1US FAERS
577Fanconi SyndromeFAERS: 1US FAERS
578Fluid overloadFAERS: 1US FAERS
579FolliculitisFAERS: 1US FAERS
580Food PoisoningFAERS: 1US FAERS
581FrustrationFAERS: 1US FAERS
582Fungal cystitisFAERS: 1US FAERS
583GastrectomyFAERS: 1US FAERS
584Gastroenteritis norovirusFAERS: 1US FAERS
585Gastrointestinal motility disorderFAERS: 1US FAERS
586Gastrointestinal viral infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
587Genital HerpesFAERS: 1US FAERS
588Genital erythemaFAERS: 1US FAERS
589Genital tract inflammationFAERS: 1US FAERS
590GlaucomaFAERS: 1US FAERS
591GlossitisFAERS: 1US FAERS
592Glucose urine absentFAERS: 1US FAERS
593GranulomaFAERS: 1US FAERS
594HaemoconcentrationFAERS: 1US FAERS
595Heat ExhaustionFAERS: 1US FAERS
596Heat StrokeFAERS: 1US FAERS
597HemiparesisFAERS: 1US FAERS
598Hepatitis AFAERS: 1US FAERS
599High density lipoprotein increasedFAERS: 1US FAERS
600Hip surgeryFAERS: 1US FAERS
601Hypertensive heart diseaseFAERS: 1US FAERS
602HyperthyroidismFAERS: 1US FAERS
603HypohidrosisFAERS: 1US FAERS
604Impaired driving abilityFAERS: 1US FAERS
605Impaired quality of lifeFAERS: 1US FAERS
606Incorrect product storageFAERS: 1US FAERS
607Incorrect route of drug administrationFAERS: 1US FAERS
608Incorrect route of product administrationFAERS: 1US FAERS
609InfestationFAERS: 1US FAERS
610Injection site bruisingFAERS: 1US FAERS
611Injection site erythemaFAERS: 1US FAERS
612Injection site vesiclesFAERS: 1US FAERS
613Insulin C-peptide increasedFAERS: 1US FAERS
614Intentional drug misuseFAERS: 1US FAERS
615Intentional product use issueFAERS: 1US FAERS
616Intercepted drug dispensing errorFAERS: 1US FAERS
617Intermittent ClaudicationFAERS: 1US FAERS
618Intervertebral Disc DegenerationFAERS: 1US FAERS
619Invasive Ductal Breast CarcinomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
620IritisFAERS: 1US FAERS
621Iron deficiencyFAERS: 1US FAERS
622Irritable Bowel SyndromeFAERS: 1US FAERS
623Joint Range of Motion DecreasedFAERS: 1US FAERS
624Ketogenic DietFAERS: 1US FAERS
625Laboratory test interferenceFAERS: 1US FAERS
626Lack of satietyFAERS: 1US FAERS
627Lactose IntoleranceFAERS: 1US FAERS
628Large intestine perforationFAERS: 1US FAERS
629Latent Autoimmune Diabetes in AdultsFAERS: 1US FAERS
630LeukopeniaFAERS: 1US FAERS
631Lichen PlanusFAERS: 1US FAERS
632Ligament ruptureFAERS: 1US FAERS
633Lip exfoliationFAERS: 1US FAERS
634Lipids abnormalFAERS: 1US FAERS
635LipoatrophyFAERS: 1US FAERS
636Lisfranc fractureFAERS: 1US FAERS
637Liver AbscessFAERS: 1US FAERS
638Loose toothFAERS: 1US FAERS
639Loss of personal independence in daily activitiesFAERS: 1US FAERS
640Lower respiratory tract congestionFAERS: 1US FAERS
641LymphadenopathyFAERS: 1US FAERS
642LymphomaFAERS: 1US FAERS
643Mastication disorderFAERS: 1US FAERS
644MastitisFAERS: 1US FAERS
645May-Thurner SyndromeFAERS: 1US FAERS
646Medical device implantationFAERS: 1US FAERS
647Medical procedureFAERS: 1US FAERS
648Medication residue presentFAERS: 1US FAERS
649MeningitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
650Metabolic alkalosisFAERS: 1US FAERS
651Metastatic NeoplasmFAERS: 1US FAERS
652MetrorrhagiaFAERS: 1US FAERS
653Muscle FatigueFAERS: 1US FAERS
654Muscle tightnessFAERS: 1US FAERS
655MyelitisFAERS: 1US FAERS
656Nasal pruritusFAERS: 1US FAERS
657Necrotising myositisFAERS: 1US FAERS
658Negative thoughtsFAERS: 1US FAERS
659NeuromaFAERS: 1US FAERS
660Noninfective gingivitisFAERS: 1US FAERS
661Obesity surgeryFAERS: 1US FAERS
662Occult blood positiveFAERS: 1US FAERS
663OligodipsiaFAERS: 1US FAERS
664Oral mucosal exfoliationFAERS: 1US FAERS
665OrchitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
666Oropharyngeal discomfortFAERS: 1US FAERS
667Orthostatic hypertensionFAERS: 1US FAERS
668OsteotomyFAERS: 1US FAERS
669OverweightFAERS: 1US FAERS
670Pain of skinFAERS: 1US FAERS
671Pancreatic NeoplasmFAERS: 1US FAERS
672Pancreatic PseudocystFAERS: 1US FAERS
673Pancreatic enzymes increasedFAERS: 1US FAERS
674PancytopeniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
675PanniculitisFAERS: 1US FAERS
676Paranasal sinus discomfortFAERS: 1US FAERS
677Pelvic InfectionFAERS: 1US FAERS
678Penile blisterFAERS: 1US FAERS
679Pericardial effusionFAERS: 1US FAERS
680PericarditisFAERS: 1US FAERS
681Perineal painFAERS: 1US FAERS
682Perineal ulcerationFAERS: 1US FAERS
683Peripheral artery occlusionFAERS: 1US FAERS
684Peripheral artery stenosisFAERS: 1US FAERS
685Personality ChangeFAERS: 1US FAERS
686PharyngitisFAERS: 1US FAERS
687PhotophobiaFAERS: 1US FAERS
688PolyarthritisFAERS: 1US FAERS
689Polymyalgia RheumaticaFAERS: 1US FAERS
690Post procedural cellulitisFAERS: 1US FAERS
691Post-Traumatic Stress DisorderFAERS: 1US FAERS
692Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
693Postoperative renal failureFAERS: 1US FAERS
694Prerenal failureFAERS: 1US FAERS
695Prescribed overdoseFAERS: 1US FAERS
696Procedural nauseaFAERS: 1US FAERS
697Product availability issueFAERS: 1US FAERS
698Product counterfeitFAERS: 1US FAERS
699Product identification number issueFAERS: 1US FAERS
700Product packaging confusionFAERS: 1US FAERS
701Prostatic ObstructionFAERS: 1US FAERS
702Pruritus allergicFAERS: 1US FAERS
703Pulmonary FibrosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
704Pulmonary painFAERS: 1US FAERS
705Pulmonary thrombosisFAERS: 1US FAERS
706PurulenceFAERS: 1US FAERS
707Quality of life decreasedFAERS: 1US FAERS
708Rectal polypFAERS: 1US FAERS
709Renal cystFAERS: 1US FAERS
710Renal massFAERS: 1US FAERS
711Renal scan abnormalFAERS: 1US FAERS
712Renal tubular disorderFAERS: 1US FAERS
713Respiratory tract infection fungalFAERS: 1US FAERS
714RetchingFAERS: 1US FAERS
715Rheumatoid ArthritisFAERS: 1US FAERS
716Rotator cuff syndromeFAERS: 1US FAERS
717Salt cravingFAERS: 1US FAERS
718SarcomaFAERS: 1US FAERS
719ScabFAERS: 1US FAERS
720SchizophreniaFAERS: 1US FAERS
721ScreamingFAERS: 1US FAERS
722Scrotal erythemaFAERS: 1US FAERS
723Septic necrosisFAERS: 1US FAERS
724Shock symptomFAERS: 1US FAERS
725ShockFAERS: 1SIDER
US FAERS
726Single functional kidneyFAERS: 1US FAERS
727Skeletal injuryFAERS: 1US FAERS
728Skin WrinklingFAERS: 1US FAERS
729Skin lacerationFAERS: 1US FAERS
730Skin tightnessFAERS: 1US FAERS
731Skin ulcer excisionFAERS: 1US FAERS
732SluggishnessFAERS: 1US FAERS
733Soft tissue inflammationFAERS: 1US FAERS
734Spermatic cord funiculitisFAERS: 1US FAERS
735Spermatozoa abnormalFAERS: 1US FAERS
736Splenic RuptureFAERS: 1US FAERS
737SplenomegalyFAERS: 1US FAERS
738StarvationFAERS: 1US FAERS
739Streptococcal urinary tract infectionFAERS: 1US FAERS
740Subcutaneous EmphysemaFAERS: 1US FAERS
741Suicide attemptFAERS: 1US FAERS
742Supraventricular tachycardiaFAERS: 1US FAERS
743Suspected counterfeit productFAERS: 1US FAERS
744Synovial CystFAERS: 1US FAERS
745TenosynovitisFAERS: 1US FAERS
746Therapeutic procedureFAERS: 1US FAERS
747Therapeutic response delayedFAERS: 1US FAERS
748Thermal burnFAERS: 1US FAERS
749Throat cancerFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
750Thrombotic strokeFAERS: 1US FAERS
751Tooth LossFAERS: 1US FAERS
752Transaminases increasedFAERS: 1US FAERS
753Transcription medication errorFAERS: 1US FAERS
754Traumatic renal injuryFAERS: 1US FAERS
755Unable to afford prescribed medicationFAERS: 1US FAERS
756UnderweightFAERS: 1US FAERS
757UreteritisFAERS: 1US FAERS
758Urethritis noninfectiveFAERS: 1US FAERS
759Urinary hesitationFAERS: 1US FAERS
760Urinary tract infection enterococcalFAERS: 1US FAERS
761UrinomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
762Vascular insufficiencyFAERS: 1US FAERS
763Venous ThrombosisFAERS: 1US FAERS
764Venous stenosisFAERS: 1US FAERS
765Vestibular NeuronitisFAERS: 1US FAERS
766Viral upper respiratory tract infectionFAERS: 1US FAERS
767Vulvovaginal inflammationFAERS: 1US FAERS
768Vulvovaginal swellingFAERS: 1US FAERS
769Wound abscessFAERS: 1US FAERS
770Wound infection staphylococcalFAERS: 1US FAERS
771Wound sepsisFAERS: 1US FAERS
772diagnostic procedureFAERS: 1US FAERS
773Adrenal Gland Diseases28916336CTD
774Atrophic vulvovaginitisCanada Vigilance: 1Canada Vigilance
775Blood phosphate increasedSIDER
776Blood phosphorus increasedSIDER
777CryingCanada Vigilance: 1Canada Vigilance
778DiuresisSIDER
779Glucose lowSIDER
780Hyperostosis25289773
28916336
CTD
781Hyperplasia25289773CTD
782Leydig Cell Tumor25289773
25398756
28916336
CTD
783Pheochromocytoma

View details

CTD
784PrurigoSIDER
785Serum potassium increasedSIDER
786Swelling of eyelidCanada Vigilance: 2Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.